CPT code 93886 represents an intracranial arterial Doppler ultrasound performed to evaluate blood flow and velocity within the arteries of the head. This diagnostic vascular study is clinically important for detecting arterial occlusion or stenosis that can precipitate cerebrovascular events such as ischemic stroke or intracranial hemorrhage. The test also serves a screening role in specific pediatric conditions, for example, sickle cell disease, where cerebral blood flow assessment informs risk stratification.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise national overview of clinical context and service settings, typical payer considerations, and operational benchmarks. The publication outlines expected sites of service, common clinical indications, and typical utilization drivers for intracranial vascular Doppler studies.

This summary equips clinicians, coding professionals, and policy stakeholders with the core facts about CPT code 93886, including what the procedure measures, why it matters for cerebrovascular risk assessment, and where it is commonly performed. Data not available in the input will be noted where applicable in subsequent sections.